These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
71 related items for PubMed ID: 7665979
1. Enhancement of erythropoietin production by selective adenosine A2 receptor agonists in response to hypoxia. Ohigashi T, Nakashima J, Aggarwal S, Brookins J, Agrawal K, Fisher JW. J Lab Clin Med; 1995 Sep; 126(3):299-306. PubMed ID: 7665979 [Abstract] [Full Text] [Related]
4. Adenosine A(2A) and A(2B) receptor activation of erythropoietin production. Fisher JW, Brookins J. Am J Physiol Renal Physiol; 2001 Nov; 281(5):F826-32. PubMed ID: 11592940 [Abstract] [Full Text] [Related]
5. Modulation of erythropoietin production by selective adenosine agonists and antagonists in normal and anemic rats. Nagashima K, Karasawa A. Life Sci; 1996 Nov; 59(9):761-71. PubMed ID: 8761029 [Abstract] [Full Text] [Related]
6. A1 and A2 adenosine receptor regulation of erythropoietin production. Ueno M, Brookins J, Beckman B, Fisher JW. Life Sci; 1988 Nov; 43(3):229-37. PubMed ID: 3398696 [Abstract] [Full Text] [Related]
7. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. Jarvis MF, Schulz R, Hutchison AJ, Do UH, Sills MA, Williams M. J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819 [Abstract] [Full Text] [Related]
8. Binding characteristics of the adenosine A2 receptor ligand [3H]CGS 21680 to human platelet membranes. Varani K, Borea PA, Guerra L, Dionisotti S, Zocchi C, Ongini E. Biochem Pharmacol; 1994 Oct 18; 48(8):1658-61. PubMed ID: 7980632 [Abstract] [Full Text] [Related]
9. [Increase in erythropoietin secretion mediated by adenosine A2 receptors]. Nakashima J, Tazaki H, Fisher JW. Hum Cell; 1993 Mar 18; 6(1):36-41. PubMed ID: 8393698 [Abstract] [Full Text] [Related]
10. Adenosine A2 receptor modulation of erythropoietin secretion in hepatocellular carcinoma cells. Nakashima J, Brookins J, Ohigashi T, Fisher JW. Life Sci; 1994 Mar 18; 54(2):109-17. PubMed ID: 8123156 [Abstract] [Full Text] [Related]
11. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands. Webb RL, Barclay BW, Graybill SC. J Pharmacol Exp Ther; 1991 Dec 18; 259(3):1203-12. PubMed ID: 1684818 [Abstract] [Full Text] [Related]
12. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. Lee YW, Yaksh TL. J Pharmacol Exp Ther; 1996 Jun 18; 277(3):1642-8. PubMed ID: 8667233 [Abstract] [Full Text] [Related]
13. Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats. Gleiter CH, Brause M, Delabar U, Zebski H, Eckardt KU. Kidney Int; 1997 Aug 18; 52(2):338-44. PubMed ID: 9263988 [Abstract] [Full Text] [Related]
14. Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Takagi H, King GL, Aiello LP. Diabetes; 1998 Sep 18; 47(9):1480-8. PubMed ID: 9726238 [Abstract] [Full Text] [Related]
15. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes. Feoktistov I, Biaggioni I. Mol Pharmacol; 1993 Jun 18; 43(6):909-14. PubMed ID: 8391117 [Abstract] [Full Text] [Related]
16. Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle. Bokník P, Neumann J, Schmitz W, Scholz H, Wenzlaff H. J Cardiovasc Pharmacol; 1997 Dec 18; 30(6):750-8. PubMed ID: 9436814 [Abstract] [Full Text] [Related]
17. Characterization of erythropoietin production in a hepatocellular carcinoma cell line. Nakashima J, Brookins J, Fisher JW. J Lab Clin Med; 1992 Mar 18; 119(3):306-14. PubMed ID: 1311742 [Abstract] [Full Text] [Related]